We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

IDEXX Laboratories Inc (IDXX) Common Stock USD0.10

Sell:$433.00 Buy:$433.35 Change: $8.45 (2.00%)
NASDAQ:1.51%
Market closed |  Prices as at close on 7 November 2024 | Switch to live prices |
Sell:$433.00
Buy:$433.35
Change: $8.45 (2.00%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 7 November 2024 | Switch to live prices |
Sell:$433.00
Buy:$433.35
Change: $8.45 (2.00%)
Market closed |  Prices as at close on 7 November 2024 | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services primarily for the companion animal veterinary, livestock and poultry, dairy and water testing industries. The Company also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. Its Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. Its LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, to improve the quality and safety of milk.

Contact details

Address:
One Idexx Drive
WESTBROOK
04092-2041
United States
Telephone:
+1 (207) 5560300
Website:
https://www.idexx.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
IDXX
ISIN:
US45168D1046
Market cap:
$34.06 billion
Shares in issue:
81.88 million
Sector:
Health Care Equipment
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
NASDAQ Comb. Composite

Key personnel

  • Jonathan Mazelsky
    President, Chief Executive Officer, Director
  • Brian Mckeon
    Chief Financial Officer, Executive Vice President, Treasurer
  • Michael Johnson
    Chief Human Resource Officer, Executive Vice President
  • Martin Smith
    Executive Vice President, Chief Technology Officer
  • Sharon Underberg
    Executive Vice President, General Counsel, Corporate Secretary
  • Michael Erickson
    Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine
  • Michael Lane
    Executive Vice President and General Manager, Global Reference Laboratories and Information Technology
  • Michael Schreck
    Executive Vice President and General Manager, Veterinary Software and Services, Corporate Accounts and Customer Experience
  • Tina Hunt
    Executive Vice President - Strategy, Sector Development and Global Operations
  • George Fennell
    Senior Vice President and Chief Revenue Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Options

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.